Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 19597109)

1.
2.

The core mechanism of dry eye disease is inflammation.

Wei Y, Asbell PA.

Eye Contact Lens. 2014 Jul;40(4):248-56. doi: 10.1097/ICL.0000000000000042. Review.

3.

Dry eye: an inflammatory ocular disease.

Hessen M, Akpek EK.

J Ophthalmic Vis Res. 2014 Apr;9(2):240-50. Review.

4.

CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease.

Kodati S, Chauhan SK, Chen Y, Dohlman TH, Karimian P, Saban D, Dana R.

Invest Ophthalmol Vis Sci. 2014 Aug 19;55(9):5871-7. doi: 10.1167/iovs.14-14481.

5.

Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Coursey TG, de Paiva CS.

Clin Ophthalmol. 2014 Aug 4;8:1447-58. doi: 10.2147/OPTH.S35685. eCollection 2014. Review.

6.

What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease?

Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R.

Am J Ophthalmol. 2014 Jan;157(1):69-77.e2. doi: 10.1016/j.ajo.2013.07.019. Epub 2013 Sep 21.

7.

T helper cytokines in dry eye disease.

Pflugfelder SC, Corrales RM, de Paiva CS.

Exp Eye Res. 2013 Dec;117:118-25. doi: 10.1016/j.exer.2013.08.013. Epub 2013 Sep 4. Review.

8.

The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.

Dohlman TH, Chauhan SK, Kodati S, Hua J, Chen Y, Omoto M, Sadrai Z, Dana R.

Invest Ophthalmol Vis Sci. 2013 Jun 12;54(6):4081-91. doi: 10.1167/iovs.12-11216.

9.

Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients.

Guyette N, Williams L, Tran MT, Than T, Bradley J, Kehinde L, Edwards C, Beasley M, Fullard R.

Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3729-37. doi: 10.1167/iovs.12-11431.

10.

Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Amparo F, Dastjerdi MH, Okanobo A, Ferrari G, Smaga L, Hamrah P, Jurkunas U, Schaumberg DA, Dana R.

JAMA Ophthalmol. 2013 Jun;131(6):715-23. doi: 10.1001/jamaophthalmol.2013.195.

11.

Dry eye as a mucosal autoimmune disease.

Stern ME, Schaumburg CS, Pflugfelder SC.

Int Rev Immunol. 2013 Feb;32(1):19-41. doi: 10.3109/08830185.2012.748052. Review.

12.

Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease.

Lee HS, Hattori T, Park EY, Stevenson W, Chauhan SK, Dana R.

Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5632-40. doi: 10.1167/iovs.12-9547.

13.

PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease.

Sadrai Z, Stevenson W, Okanobo A, Chen Y, Dohlman TH, Hua J, Amparo F, Chauhan SK, Dana R.

Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3584-91. doi: 10.1167/iovs.11-9110.

14.

Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Barabino S, Chen Y, Chauhan S, Dana R.

Prog Retin Eye Res. 2012 May;31(3):271-85. doi: 10.1016/j.preteyeres.2012.02.003. Epub 2012 Mar 8. Review.

15.

Dry eye disease: an immune-mediated ocular surface disorder.

Stevenson W, Chauhan SK, Dana R.

Arch Ophthalmol. 2012 Jan;130(1):90-100. doi: 10.1001/archophthalmol.2011.364. Review.

16.

Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.

Xie P, Kamei M, Suzuki M, Matsumura N, Nishida K, Sakimoto S, Sakaguchi H, Nishida K.

PLoS One. 2011;6(12):e28933. doi: 10.1371/journal.pone.0028933. Epub 2011 Dec 19.

17.

Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.

Pflugfelder SC.

Am J Ophthalmol. 2011 Dec;152(6):900-909.e1. doi: 10.1016/j.ajo.2011.08.023. Epub 2011 Oct 22.

18.

Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.

Lee HS, Chauhan SK, Okanobo A, Nallasamy N, Dana R.

Cornea. 2011 Dec;30(12):1465-72. doi: 10.1097/ICO.0b013e31821c9b5a.

19.

Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.

Goyal S, Chauhan SK, Dana R.

Arch Ophthalmol. 2012 Jan;130(1):84-9. doi: 10.1001/archophthalmol.2011.266. Epub 2011 Sep 12.

20.

Interferon-γ-secreting NK cells promote induction of dry eye disease.

Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R.

J Leukoc Biol. 2011 Jun;89(6):965-72. doi: 10.1189/jlb.1110611. Epub 2011 Mar 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk